Pharmather Holdings LtdCanadian Securities Exchange:PHRMView on OTCQB
- LAST PRICE0.2200
- TODAY'S CHANGE (%)0.0050 (2.3256%)
- Bid / Lots0.2000/ 7
- Ask / Lots0.2250/ 146
- Open / Previous Close0.2150 / 0.2150
- Day Range
- 52 Week Range
- Volume69,080
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PHRM |
|---|---|---|
| 09:32 ET | 500 | 0.215 |
| 09:46 ET | 10000 | 0.215 |
| 10:45 ET | 500 | 0.22 |
| 11:30 ET | 5500 | 0.22 |
| 01:45 ET | 2000 | 0.225 |
| 03:03 ET | 50000 | 0.22 |
Nov 13, 2024
Oct 23, 2024
PharmaTher Receives Complete Response Letter from the U.S. Food and Drug Administration for Ketamine Abbreviated New Drug Application, from 8:00AM ET on Wednesday Oct 23, 2024 by Dow Jones
8:00AM ET on Wednesday Oct 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pharmather Holdings Ltd | 19.0M | -9.0x | --- |
Devonian Health Group Inc | 19.3M | -6.0x | --- |
Kane Biotech Inc | 13.8M | -2.5x | --- |
Cytophage Technologies Ltd | 13.5M | -0.8x | --- |
BioNxt Solutions Inc | 26.6M | -3.9x | --- |
Preveceutical Medical Inc | 10.8M | -8.5x | --- |
Company Information
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.
Contact Information
- Headquarters
- 82 Richmond Street EastTORONTO, BC, Canada M5C 1P1
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $19.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 88.5M |
Pharmather Holdings Ltd does not pay a dividend. | |
Beta | 3.34 |
EPS | $-0.02 |
Book Value | $0.03 |
P/E Ratio | -9.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
